The FDA granted approval to Eli Lilly and Company’s mirikizumab-mrkz (Omvoh) for Crohn disease, expanding its treatment reach ...

Learn why white rice, mashed potatoes, fruits without the skin, and other low-fiber and low-residue foods are your best bet ...

Louise Thompson has opened up about her future health procedures on her podcast, He Said She Said. The Lucky author and Made ...

Once remission has been achieved, however, there is no evidence that steroid enemas will maintain the remission. [27] Thus with the risk of cumulative systemic absorption of topically administered ...

Omvoh (mirikizumab-mrkz) for moderately to severely active Crohn’s disease in adults. Omvoh is now approved in the U.S. for ...

The Crohn’s and Colitis Foundation’s 34th annual Torch Gala is set to take place on Saturday, Feb. 8 in Atlanta, with three ...

Crohn’s disease and ulcerative colitis (UC) are both types of inflammatory bowel disease (IBD) that share similar symptoms but differ in their affected areas, disease progression, and treatment ...

Massachusetts gastrointestinal disease firm, Cristcot, has announced results from its Phase III trial examining its hydrocortisone suppository and applicator for ulcerative colitis (UC), finding ...

Love Is Blind’ alum Kwame Appiah says he was ‘forced to change’ his lifestyle after being diagnosed with ulcerative colitis ...

Company on track to report topline data in first half of 2025Positive preliminary data from all five single ascending dose (SAD) cohorts ranging ...

(RTTNews) - Palisade Bio, Inc. (PALI), Thursday announced a preliminary data from five planned Single Ascending Dose cohorts, showing that PALI-2018 was well-tolerated among doses ranging from 15 mg ...

Tulisokibart, a TNF–like cytokine 1A monoclonal antibody, has demonstrated significant potential in inducing clinical ...